throbber
Characteristics of Exudative Age-
`related Macular Degeneration
`Determined In Vivo with
`Confocal and Indirect Infrared
`Imaging
`
`M. Elizabeth Hartnett, MD,"2 Ann E. Elsner, PhD"
`
`Purpose: To evaluate the current and future interventions in age-related macular
`degeneration (AMD), it is essential to delineate the early clinical features associated
`with later visual loss. The authors describe the retinal pigment epithelium (RPE)/Bruch
`membrane region in ten patients with advanced exudative AMD using current angio-
`graphic techniques and a noninvasive method: infrared (IR) imaging with the scanning
`laser ophthalmoscope.
`Methods: Ten patients with exudative AMD, evidenced by choroidal neovascular-
`ization (CNV), fibrovascular scar formation, pigment epithelial detachment, or serous
`subretinal fluid, were examined using IR imaging, fluorescein angiography, indocyanine
`green angiography, and stereoscopic viewing of fundus slides. The authors determined
`the number and size of drusen and subretinal deposits and the topographic character
`of the RPE/Bruch membrane area and of CNV.
`In all patients, IR imaging yielded the greatest number of drusen and sub-
`Results:
`retinal deposits. Sheets of subretinal material, but few lesions consistent with soft drusen,
`were seen. Infrared imaging provided topographic information of evolving CNV. Choroidal
`neovascularization appeared as a complex with a dark central core, an enveloping re-
`flective structure which created a halo-like appearance in the plane of focus, and outer
`retinal/subretinal striae.
`Infrared imaging provides a noninvasive, in vivo method to image
`Conclusions:
`early changes in the RPE/Bruch membrane. It offers advantages over current imaging
`techniques by minimizing light scatter through cloudy media and enhancing the ability
`to image through small pupils, retinal hyperpigmentation, blood, heavy exudation, or
`subretinal fluid. It provides additional information regarding early CNV, and the character
`of drusen and subretinal deposits. Ophthalmology 1996;103:58-71
`
`Originally received: October 6, 1994.
`Revision accepted: July 3, 1995.
`Harvard University, Cambridge.
`
`2 Schepens Retina Associates, Boston.
`
`3 Schepens Eye Research Institute, Boston.
`
`Presented at the ARVO Annual Meeting, Sarasota, May 1994.
`
`Supported by DOE DE-FG 02-91ER61229, EY08794-01A1, and the
`Perkin Fund, New Canaan, Connecticut.
`The authors have no proprietary interest in the equipment or technology
`used in this study, other than grant support for research.
`
`The clinical features of patients with age-related macular
`degeneration (AMD) have been classified to determine
`early findings predictive of later sight loss, namely cho-
`roidal neovascularization (CNV), retinal atrophy, and
`pigment epithelial detachments. I-3 Yet, many classifica-
`tion schemes fail to provide reliable and repeated infor-
`mation predictive of the subsequent anatomic and visual
`outcomes in all patients. Greater understanding of the
`
`Reprint requests to M. Elizabeth Hartnett, MD, Schepens Retina As-
`sociates, 100 Charles River Plaza, Boston, MA 02114.
`
`58
`
`HAAG-STREIT AG - EXHIBIT 1022
`Page 1 of 14
`
`

`

`Hartnett and Elsner • In Vivo Infrared Imaging in Exudative AMD
`
`pathophysiology of AMD is needed. Further insight into
`the nature of drusen and subretinal topography may help
`to differentiate among the varying precursor stages in
`AMD and their corresponding outcomes. Appropriate
`medical intervention then can be determined and tested
`for effectiveness.
`Information about size, extent, and composition of
`drusen and the choroidal vasculature may be masked in
`clinical examination and stereoscopic fundus photography
`by the overlying retina, retinal pigment epithelium (RPE),
`or by the lack of contrast in heavily or lightly4 pigmented
`fundi. In fluorescein angiography, masking occurs because
`of the melanin and xanthophyll pigments, blood, heavy
`exudation, dense subretinal fluid, or overlying retinal vas-
`cular hyperfluorescence. The choroidal circulation and
`choriocapillaris are not well resolved. Through indocy-
`anine green angiography (ICGA), some drusen are im-
`aged,5 but most drusen are not demonstrated, and the
`choriocapillaris is not well visualized. Recent clinicohis-
`topathologic correlations suggest that clinical definitions
`of drusen do not correspond to their presumed histo-
`pathologic determinants.' There is a need to obtain a bet-
`ter image of the RPE/Bruch membrane region in a non-
`invasive way in vivo and to define and follow the early
`precursor lesions of patients with AMD longitudinally.
`Many patients with AMD and visual impairment have
`other concomitant ocular disorders, such as glaucoma,
`cataract, or pseudophakia. Such patients may be rejected
`from studies because of the technical inability to image
`their maculas adequately. Yet, their eyes may provide
`valuable information and are representative of eyes typ-
`ically found in this age group and in AMD.
`We chose a group of patients seen consecutively by the
`same retinal specialist, all of whom had AMD with visual
`impairment. Although small in number, this population
`represents a realistic cross-section of patients referred to
`retinal specialists for visual loss secondary to AMD. We
`used infrared (IR) imaging with the scanning laser
`ophthalmoscope (SLO) in direct confocal and indirect
`modes' to compare drusen and the subretinal topogra-
`phy seen in these patients with clinical evaluation and
`more standard methods of imaging, fluorescein angiog-
`raphy (FA), stereoscopic fundus slides (FS), and, in some
`cases, ICGA. We found that drusen seen on clinical ex-
`amination correspond to some elevated, discrete subret-
`inal deposits seen with IR imaging. Yet, we were able to
`see a greater number of similar-appearing subretinal de-
`posits and of the RPE/Bruch membrane topography with
`IR imaging than what we saw by clinical evaluation. We
`believe that IR imaging may be a valuable in vivo method
`that provides greater information and thus a greater un-
`derstanding of the RPE/Bruch membrane region.
`
`Patients and Methods
`
`Patients
`
`Our study population included ten consecutive patients
`referred for retinal evaluation because of visual impair-
`
`ment from AMD (Table 1). All patients had wet AMD
`diagnosed because of large confluent soft drusen,' pigment
`epithelial detachment (PED), CNV, subretinal fluid, and/
`or fibrovascular scar formation in one or both eyes. In
`two patients, the less-involved eye had either presumed
`pigment (case 1) or large confluent drusen (case 3). In
`case 1, there was initially no clinical suspicion of wet AMD
`in the fellow, less-involved eye before IR imaging. In the
`remaining eight patients in whom extensive pathology in
`one eye precluded the imaging of drusen and subretinal
`deposits in the macula, only the fellow, less-involved eye
`was studied. In these eight study eyes, wet AMD mani-
`fested by drusen, PED, CNV, or subretinal hemorrhage.
`No patient was excluded due to media opacity, small pu-
`pil, or intraocular lens (IOL) because these conditions of-
`ten coexist with AMD in this age group. A sampled mac-
`ular region of each of the study eyes allowed viewing of
`drusen and subretinal deposits by the greatest number of
`methods possible by avoiding areas masked by the exu-
`dative process. The imaging data were collected prospec-
`tively and analyzed at a later time.
`No patient had a previously known allergy to fluores-
`cein. No patient with an allergy to ICG or iodine under-
`went ICGA. Written informed consent before participa-
`tion was obtained from all patients. The protocol was
`reviewed and approved by the Institutional Review Board
`of the Schepens Eye Research Institute and included con-
`fidentiality of results.
`
`Clinical Examination and Angiography
`All patients underwent a thorough ophthalmologic ex-
`amination, including funduscopic biomicroscopy of both
`maculas. Stereoscopic color FS, FA, and, in seven eyes in
`which FA alone failed to provide adequate clinical infor-
`mation, ICGA using the SLO, were performed. In patients
`referred from outside areas, photographs and imaging
`studies were requested. Testing was performed at this in-
`stitution based on the individual clinical need of the pa-
`tients to be cost effective in today's healthcare environ-
`ment. Photographic FAs were performed in standard
`fashion with an intravenous, antecubital injection of 5
`ml 10% sodium fluorescein, followed by sequential fundus
`photographs using a Zeiss (Oberkochen, Germany), Top-
`con (Tokyo, Japan), or Kowa (Tokyo, Japan) fundus
`camera. Stereo pairs of the macula were taken during the
`transit phases. Scanning laser ophthalmoscope FAs (cases
`7 and 9; Table 1) were performed using 488-nm excitation
`light, 160 /./W at the cornea, and a Schott OG 515 filter
`(Glass Technologies, Inc, Duryea, PA). Scanning laser
`ophthalmoscope ICGAs were performed in seven patients
`using an 805-nm excitation light, 0.7 to 1 mW at the
`cornea, and an 810-nm long-pass filter. Indocyanine green,
`reconstituted with 3 to 5 ml diluent, was given as a 3-ml
`injection into the antecubital vein, followed by a saline
`flush, and viewed as a 40° field of view. A repeat injection
`of 2 ml was given for a 20° field of view after allowing
`sufficient time for recirculation of the original bolus of
`ICG. This was done only in those patients in whom min-
`imal pooling of dye was present, and the additional bolus
`
`59
`
`HAAG-STREIT AG - EXHIBIT 1022
`Page 2 of 14
`
`

`

`Ophthalmology Volume 103, Number 1, January 1996
`
`Table 1. Demographics of Patients*
`
`Indocyanine Green
`Angiography
`
`Case
`No.
`
`Age
`(yrs)
`
`Sex
`
`Hypertensiont
`
`1
`
`2
`3
`
`4
`5±
`
`6
`
`7
`
`8
`9
`10§
`
`59
`
`79
`73
`
`86
`92
`
`79
`
`74
`
`86
`91
`81
`
`M
`
`M
`M
`
`F
`F
`
`F
`
`F
`
`F
`F
`M
`
`—
`+
`—
`
`Eye
`OD
`OS
`OD
`OD
`OS
`OS
`OS
`
`OD
`
`OD
`
`OD
`OS
`OD
`
`Clincal Macular
`Appearance
`Pigment
`CNV
`Treated CNV
`Drusen
`Subretinal fluid
`PED
`Subretinal fluid,
`occult CNV
`PED, occult
`CNV
`Drusen, shallow
`PED
`Subretinal heme
`Occult CNV
`PED, subfoveal
`occult CNV
`
`PED = pigment epithelial detachment; CNV = choroidal neovascularization.
`The fellow eyes of cases 2 and 4 through 10 had fibrovascular scars precluding adequate viewing of drusen and
`subretinal deposits; therefore, only one study eye in each of these patients was included in the study.
`t All hypertension was controlled with medications.
`f Patient had glaucoma.
`§ Patient had a history of cardiovascular disease.
`
`was believed to be needed for information in the 20° field
`after the 40° videoangiogram was reviewed. Indocyanine
`green angiography was not performed in three patients.
`Case 1 had a well-defined CNV in the left eye, and ICGA
`was not required for diagnosis. Cases 3 and 9 had iodine
`allergies. All patients underwent IR imaging using the
`SLO. Infrared imaging was performed before ICGA when
`both were to be performed.
`
`Stereoscopic Fundus Photographs
`Color stereo pairs of FS were viewed on a light box with
`stereo viewers (X4 magnification) by the same observer,
`with the room lights off to achieve the best contrast pos-
`sible.
`The more focused slide of the stereo pair from the FS,
`or red-free slide when the FS was not available, was viewed
`on a slidex (approximately X8 magnification). A trans-
`parent grid with 1-mm2 boxes was superimposed onto the
`image on the slidex. Outlines of the drusen, optic nerve,
`and blood vessels were drawn onto the overlay. A sampled
`macular region was determined and drawn in to represent
`the largest area of the macula that provided the best avail-
`able quality data by all methods. From this area, counting
`of drusen and subretinal deposits was performed. The ap-
`proximate area of the sampled macular region in deg2 was
`calculated by dividing the area in each slide (number of
`millimeter-squared boxes from the transparent grid over-
`lays) by the normalized area of the entire slide (number
`
`of millimeter-squared boxes per deg2 of field; 30°, Zeiss;
`50°, Topcon or Kowa). The sampled macular region in
`relation to the center of the foveal avascular zone for each
`eye was superotemporal in three eyes of three patients,
`superonasal in one eye or one patient, superior hemi-
`macular in one eye of one patient, temporal in one eye
`of one patient, inferior nasal in four eyes of four patients,
`and included the entire macula in two eyes of one patient.
`The mean ± standard deviation for the sampled macular
`region was 152 ± 79.6 deg2.
`The slide then was projected using a Kodak slide pro-
`jector (Rochester, NY) (approximately X33 magnifica-
`tion).
`
`Red-free Fundus Photographs and Fluorescein
`Angiography
`Red-free photographs and FA were viewed in a similar
`manner to FS slides. Drusen were seen either as subretinal
`low-density lesions (on red-free photographs) or as early
`hyperfluorescing or late staining subretinal lesions (on
`FAs). In two eyes (cases 7 and 9; Table 2), drusen were
`counted from a red-free or FA still frame from a videoan-
`giogram.
`
`Infrared Imaging
`Video images were obtained using the SLOT with a tune-
`able infrared laser (Ti:Sapphire SEO, Concord, MA; 795-
`
`60
`
`HAAG-STREIT AG - EXHIBIT 1022
`Page 3 of 14
`
`

`

`Hartnett and Elsner • In Vivo Infrared Imaging in Exudative AMD
`
`Table 2. Subretinal Deposit and Drusen Characteristics and Number by Different Imaging Techniques
`
`FA
`Fluorescence
`Late
`Early
`
`NA
`
`NA
`
`Case
`No.
`1
`
`2
`3
`
`4
`5
`6
`7
`8
`9
`10
`
`Eye
`OD*
`OS*
`OD
`OD
`OS
`OS
`OS
`OD
`ODt
`OD
`OSt
`OD
`
`Lens
`Status
`Phakic
`Phakic
`IOL
`Phakic, NS
`Phakic, NS
`Phakic, NS
`IOL
`Phakic, NS
`Phakic, NS
`Aphakic
`IOL
`Phakic
`
`FS
`(4X)
`0
`2
`NA
`76
`64
`8
`20
`42
`NA
`19
`NA
`NA
`
`Red-free
`(4X)
`0
`1
`9
`28
`21
`12
`0
`24
`9
`21
`56
`0
`
`FA
`(4X)
`8
`37
`15
`0
`0
`3
`71
`38
`32
`7
`24
`3
`
`8X
`0
`2
`28
`62
`80
`8
`24
`45
`NA
`21
`NA
`3
`
`33X
`0
`6
`45
`82
`92
`10
`24
`42
`NA
`30
`NA
`NA
`
`IR >80 lam
`2
`15
`5
`43
`6
`188
`3
`125
`12
`104
`3
`35
`53
`4
`19
`87
`17
`384
`77
`7
`79
`7
`69
`1
`
`Sampled Macular
`Region (deg2)*
`237
`293
`93
`136
`79
`156
`274
`102
`121
`96
`50
`190
`
`FA = fluorescein anigiogram; FS = fundus slide; IR = infrared image; OD = right eye; OS = left eye; IOL = intraocular lens; NA = not applicable;
`NS = nuclear sclerosis.
`* Based on fundus slide field of view 30° (Zeiss), 50° (Topton, Kowa).
`t Subretinal deposits and drusen counted from FA videoangiogram.
`t Poor-quality FA secondary to small pupil and IOL precluded adequate imaging.
`
`895 nm)."° Typically, 805-, 835-, 865-, and 895-nm
`wavelengths were used with powers from 40 to 200 µW.
`This is noninvasive and not uncomfortable or fatiguing
`to the patient. Although parametric data were collected
`in this article, clinically useful data could be obtained
`quickly.
`Confocal imaging was performed initially (Fig 1A).
`Focusing was determined at the optical plane of the major
`retinal blood vessel walls for each wavelength tested. The
`light reflected from the macula was allowed to return
`through a central annulus of 200 or 800 µm. In the highly
`confocal image (200-µm aperture) light focused at the de-
`sired optical plane returned to the detector with little light
`from other tissue planes. In the direct mode, a larger ap-
`erture of 400 to 800 Am allowed a higher proportion of
`light from deeper layers of the retina to return to the de-
`tector. This direct mode was helpful in determining the
`optical plane desired for viewing subretinal structures and
`pathology 1° and will represent the aperture used when the
`term confocal is used. Highly confocal will indicate the
`200-µm aperture. We found that 835- and 865-nm wave-
`lengths were the most helpful in evaluating the RPE/Bruch
`region membrane and deep retinal region.
`Once the desired optical plane was set, indirect mode
`imaging of the macula was performed (Fig 1B). Here, the
`aperture was of a larger diameter with the central circular
`area occluded. Directly reflected light was blocked, allow-
`ing light scattered from the deeper retinal layers to return
`to the detector. The central occluded areas were 200 or
`800 Am in diameter. The 800-µm diameter stop was used
`in this article to count subretinal deposits in digitally stored
`images.
`
`Each transparent grid overlay derived from the slidex
`( X8 magnification) indicating the drusen in the sampled
`macular region of a study eye was compared with captured
`computer videoimages indicating subretinal deposits seen
`on IR imaging.
`
`Determination of the Number of Drusen and
`Subretinal Deposits
`Drusen and subretinal deposits were counted separately
`using color FS, FA, red-free slides, and IR imaging from
`the sampled macular region as described. Subretinal de-
`posits, were defined as areas of elevation viewed on IR
`images that may or may not correspond directly to clinical
`drusen. Those subretinal deposits seen on IR images that
`corresponded directly to subretinal deposits viewed by FS
`and defined as clinical drusen also were referred to as
`subretinal deposits in the IR images. Other subretinal de-
`posits, viewed on IR imaging, although similar in ap-
`pearance to deposits corresponding to clinical drusen, were
`not called drusen if no clinical counterparts were noted,
`but were included with subretinal deposits. Therefore,
`drusen was retained as a clinical term and used in de-
`scribing subretinal structures with FS, red-free slides, and
`FA. Subretinal deposits described clinical drusen and other
`small, discrete, elevated lesions seen on IR imaging alone.
`All drusen and subretinal deposits were counted and re-
`corded.
`Drusen and subretinal deposits were counted by the
`same individual (MEH) three times. The variability of
`counts was 2% or less for FS, FA, and red-free slides and
`4% or less for IR videoimages. On FS, FA, and red-free
`
`61
`
`HAAG-STREIT AG - EXHIBIT 1022
`Page 4 of 14
`
`

`

`A
`
`ap,atturi, r..osItion
`
`traction
`Intr
`
`t
`
`Bruch's mernbrarre
`
`r
`choriocapillarls law
`
`Top, Figure 1. A, confocal imaging, direct mode. Directly reflected light enters central annulus. Fibrin at the edges of the choroidal neovascularization
`(CNV) complex reflects more light (thick arrow). Less light is reflected from the active neovascular areas because hemoglobin absorbs light (thin
`arrow). We believe the halo-like appearance seen at the plane of focus represents the greater reflected light and the central dark area represents
`neovascular channels. B, indirect mode. Scattered light from deeper layers (small diagonal arrows) passes through the annular aperture, whereas
`reflected light is blocked by the central stop. Little light is reflected from the center of the CNV because it is absorbed by hemoglobin (thin arrows).
`A higher degree of scattering of light is likely where fibrin density is greatest (thick arrows).
`Center and bottom, Figure 2. Fundus photography (center left) and late frame of fluorescein angiogram (center right) of case 1 (right eye), initial
`evaluation, show a pigmented, deep, flat area inferior to the fovea. Bottom left, an indirect infrared image (865 nm) of the same eye, visit 1, shows
`an elevated lesion with a dark central core and a surrounding elevated lighter halo-like appearance in the plane of focus. Bottom right, fluorescein
`angiogram of case 1 (right eye), visit 2, 4 months later, shows choroidal neovascularization. Note similarity of this fluorescein angiogram to the previous
`infrared image, visit 1.
`
`62
`
`HAAG-STREIT AG - EXHIBIT 1022
`Page 5 of 14
`
`

`

`Hartnett and Elsner • In Vivo Infrared Imaging in Exudative AMD
`
`slides, there was minimal confluence of drusen. The
`greatest obstacles in counting drusen were small pupils
`and media opacities precluding good-quality photographs.
`Although small pupils and media opacities did not present
`obstacles to imaging the macular area by IR imaging, the
`confluence of clinical drusen made it more difficult to
`appreciate individual subretinal deposits.
`Statistical determination of the number of drusen and
`subretinal deposits and the effects of magnification or im-
`aging method were determined using nonparametric
`methods. Where two eyes were quantified, results were
`averaged so that sample sizes were determined by the
`number of patients. No data were pooled across method,
`so that the sample size for each data analysis depended
`on the number of patients who had good-quality images
`for each method in the analysis.
`
`Determination of Subretinal Deposit Size and
`Character (elevation, fluorescence)
`
`Approximate size of subretinal deposits was determined
`by counting the pixels on the computer images of captured
`IR indirect images and multiplying by 20 Am/pixel (based
`on optical data from Rodenstock (Ottobrunn-Riemerling,
`Germany) and our calibration for the emmetropic eye).
`The IR indirect images provided the best views from which
`to count elevated subretinal deposits. Small subretinal de-
`posits were designated as having diameters 80 Am or less,
`because this was the smallest diameter believed to accu-
`rately reflect the size of the deposit, given the resolution
`of the IR images, and to meet the definition of hard drusen
`less than 63 Am in diameter." The borders of clinically
`apparent drusen on FS were appreciated easily on IR im-
`ages. However, the distinct borders of smaller subretinal
`deposits that were not visible on FS are not always well
`appreciated by IR imaging because of the small size of
`the deposits (the accuracy in quantifying size of small
`subretinal deposits is 20% or lower).
`The characteristics of drusen and subretinal deposits
`were evaluated as follows. Size determination was used
`to define hard drusen ( 80 Am in diameter)." The pres-
`ence of elevation was determined using the stereo viewers
`when viewing stereo pairs of FS, FA, and red-free slides,
`and by shadows cast by thickened regions or motion par-
`allax in video using IR imaging in the indirect mode. The
`fluorescence characteristics of drusen were determined as
`early hyperfluorescence occurring during the arteriolar to
`venous flow stages, and late fluorescence as that occurring
`after arteriolar—venous phases. Drusen were counted as
`hyperfluorescent only if their fluorescence was greater than
`the background choroidal fluorescence.3
`
`Figure 3. Top, fluorescein angiogram of a well-defined subfoveal choroidal
`neovascularization (CNV) in the left eye of case 1, with surrounding
`window defects, some of which correspond to fundus slide drusen and
`infrared (IR) subretinal deposits. Bottom, indirect IR image (865 nm) of
`subfoveal CNV in the left of case 1 shows a dark central core with a
`surrounding elevated halo-like area with an additional dark area sur-
`rounded by a lighter area. This appearance suggested a multilayered CNV
`complex. Also notice that subretinal deposits nasal to the CNV appear
`as elevated lighter lesions. The window defects noted on fluorescein
`angiography are outlined in black. Notice good correspondence but a
`greater number of subretinal deposits noted by IR imaging, as evidenced
`by elevated areas of the same size with shadowing.
`
`Case Reports
`
`Case 1. A 59-year-old man noted gradual blurring of his
`central vision in the left eye 1 month previously. His medical
`history included a previous cholecystectomy and appendectomy.
`Otherwise, he had good health. He had two siblings with AMD.
`
`Visual acuity was 20/20 in the right eye and 20/200 in the
`left. Intraocular pressures were 11 mmHg in the right eye and
`12 mmHg in the left. Anterior segment showed no inflammation
`and mild nuclear sclerosis in both eyes. Results of fundus
`examination of the macula in the right eye showed a well-
`demarcated, deeply pigmented area abutting the fovea and
`extending inferior to it (Fig 2, center left). There was no associated
`
`63
`
`HAAG-STREIT AG - EXHIBIT 1022
`Page 6 of 14
`
`

`

`Figure 4. Top left, red-free image of the right eye shows a treated area below the fovea (visit 1, case 2) with few drusen-like deposits noted in the
`macula. Top right, late frame of fluorescein angiogram in the right eye shows areas of previous photocoagulation and faint fluorescence at the
`boundary between the earlier treated area (rounder, lower area of hypofluorescence) and most recent treatment area (upper, triangular area). Also
`notice hyperfluorescence in the earlier area of treatment (lower). Center left, "highly confocal" infrared (IR) image (835 nm) of case 2 (right eye)
`shows fine, deep, radiating striae extending superonasal from the foveola. Notice the dark central core and halo-like appearance in the plane of focus
`above the area of treatment. This appeared elevated, unlike the clinical appearance. Also notice numerous surrounding elevated subretinal deposits.
`An 835-nm IR image was used for this image to show subretinal features and maintain retinal landmarks for comparison. Center right, indirect
`
`64
`
`HAAG-STREIT AG - EXHIBIT 1022
`Page 7 of 14
`
`

`

`Hartnett and Elsner • In Vivo Infrared Imaging in Exudative AMD
`
`IR image (865 nm) of the same eye. Notice the appearance of elevated, discrete, subretinal deposits and of sheets of subretinal material. Bottom left,
`early phase indocyanine green angiogram shows no clear, lacy filling of choroidal neovascularization. Bottom right, late-phase indocyanine green
`angiogram without evidence of a late hot spot. Notice inferior hypofluorescence of an earlier treated area and superior triangular hypofluorescence,
`corresponding to the most recent area of treatment as seen on the fluorescein angiogram (Fig 4, top right). Any faint hyperfluorescence is believed
`to represent staining between these two areas.
`
`elevation, exudation, hemorrhage, or drusen. The macula in the
`left showed an area of retinal elevation involving the fovea with
`a few drusen located near it. Neither eye had vitreous cells, histo-
`like spots, or peripheral streaks. Both eyes had mild peripapillary
`atrophy.
`A late frame of the FA in the right eye showed a well-
`demarcated hypofluorescent area with surrounding staining but
`no definite leakage, corresponding to the area of pigmentation
`seen clinically (Fig 2, center right). In the left eye, there was a
`lacy area of early hyperfluorescence with leakage consistent with
`a well-defined CNV (Fig 3, top). There were a few window defects
`believed to be drusen, because they corresponded to clinical
`drusen seen surrounding the membrane.
`Infrared imaging of Bruch membrane area by confocal,
`direct, and indirect modes showed numerous subretinal
`deposits that were small and elevated, located temporal to the
`optic nerve and throughout the macula. The area, believed to
`be pigment in the right eye, was elevated on indirect viewing
`with a halo-like appearance in the plane of focus (Fig 2, bottom
`left). The left eye showed a multilayered structure with
`concentric dark and lighter, thickened areas. The surrounding
`macula showed numerous elevated subretinal deposits as seen
`on IR indirect imaging (Fig 3, bottom). These appeared to be
`small, discrete areas determined to be elevated by motion
`parallax and shadowing. The drusen apparent on FS, and FA
`corresponded to a number of subretinal deposits seen on IR
`imaging. However, many more subretinal deposits were seen
`on IR imaging. The patient desired no laser treatment and was
`requested to return in 1 month. He was lost to follow-up until
`4 months later. Visual acuity in the right eye had worsened to
`20/30. The FA showed a well-defined subfoveal CNV (Fig 2,
`bottom right) in the area noted to be elevated by IR imaging
`on previous evaluation.
`Here, the diagnosis was not clearly AMD, although the history
`and results of clinical examination did not support an alternative
`diagnosis. Infrared imaging supported the diagnosis of AMD
`based on a greater number of subretinal deposits/drusen than
`that appreciated clinically on FS or FA. It also imaged the core
`and surrounding halo in the right eye, which had a similar
`appearance to the subfoveal CNV only appreciated on FA 4
`months later (compare Fig 2, bottom).
`Case 2. A 79-year-old man who had had focal laser treat-
`ments three times in the right eye for CNV and subsequent
`recurrences secondary to AMD presented for a second opinion.
`His initial CNV occurred approximately 2 months after un-
`eventful cataract surgery with IOL implantation. He was first
`seen at our laboratory approximately 2 weeks after his last laser.
`He had no further distortion. His left eye had lost central vision
`7 years earlier from subfoveal CNV successfully closed with
`photocoagulation.
`On examination, visual acuity was 20/30 in the right eye
`and counting fingers in the left. Intraocular pressures were
`15 mmHg in the right eye and 18 mmHg in the left. Anterior
`segment biomicroscopy was significant only for a well-posi-
`tioned posterior chamber IOL in the right eye and nuclear
`sclerosis in the left. The clinical appearance and red-free slide
`
`showed a flat, dry, atrophic area with few surrounding drusen
`(Fig 4, top left). The FA showed an early hypofluorescent area
`inferior to the foveola extending into the foveal avascular
`zone, representing previous photocoagulation and faint flu-
`orescence at the boundary between the earlier treated area
`and the most recent treatment area. In the late phases of the
`FA, there was an area of hyperfluorescence in the center of
`the earlier treated area inferior to the fovea (Fig 4, top right).
`Small, discrete, hyperfluorescing drusen were viewed early in
`the FA surrounding the treatment area. There was leakage
`from a fibrovascular scar in the left eye.
`Highly confocal IR imaging showed the treatment area with
`an elevated area superiorly. Fine, radiating, retinal striae were
`noted off the superior aspect of the treated area (Fig 4, center
`left). The indirect mode showed a halo-like appearance sur-
`rounding the treatment area. Surrounding this halo-like ap-
`pearance were sheets of elevated subretinal deposits throughout
`the macula (Fig 4, center right). Indocyanine green angiography
`showed a dark area corresponding to previous laser and to the
`hypofluorescent area on FA. An area of faint hyperfluorescence
`between early laser treatment and the most recent treatment
`corresponded to a similar area on FA, but no hyperfluorescence
`was noted inferior to this within the old treatment scar where
`an area of hyperfluorescence was of concern on FA (Fig 4, bot-
`tom). The patient was followed.
`He returned 21 months later with a drop in visual acuity to
`20/70. Results of his clinical examination showed the dry scar
`as noted previously, with retinal elevation and a subretinal hem-
`orrhage extending under the fovea in the foveal avascular zone.
`Confocal imaging showed elevation above the treatment scar
`with fine, radiating striae extending superior and nasal to the
`scar (Fig 5, top left). On ICGA, a subfoveal CNV with a feeding
`vessel extending from within the scar was appreciated (Fig 5,
`top right). Treatment of the feeding vessels and recurrent CNV
`was only initially successful. The patient returned 11 months
`later with another recurrence. Note the red-free image with re-
`currence through the fovea with subretinal hemorrhage in Figure
`5, bottom left. Highly confocal IR imaging showed deep retinal
`striae, elevation of subretinal deposits, and thickened areas (Fig
`5, bottom right), which appeared more expansive than the IR
`image from the previous examination.
`Here, IR imaging provided earlier topographic information
`of a questionable area of recurrence of CNV within the laser
`treatment area on visit 1.
`
`Results
`
`We studied ten patients (6 women, 4 men), ranging in
`age from 59 to 92 years (mean, 80 years). Three patients
`had medically controlled hypertension and one had a his-
`tory of cardiovascular disease (Table 1).
`A total of 12 eyes (7 right eyes and 5 left eyes) are
`described. One patient had glaucoma. Six patients were
`phakic (7 eyes), 3 patients had IOLs (3 eyes), and 1
`
`65
`
`HAAG-STREIT AG - EXHIBIT 1022
`Page 8 of 14
`
`

`

`Ophthalmology Volume 103, Number 1, January 1996
`
`patient was aphakic (Table 2). One patient (1 eye) had
`asteroid hyalosis. These reflectile particles were noted
`at the shorter IR wavelengths (e.g., 805 nm) but did not
`interfere with FA, ICGA, or IR imaging at longer wave-
`lengths.
`
`Subretinal Deposit Number
`Drusen defined by clinical FS, FA, and red-free images
`corresponded in location with some subretinal deposits
`seen on IR imaging, and we therefore believe that these
`deposits represent the topographic appearances of drusen
`(Table 2). Although we do not know the nature of the
`other subretinal deposits

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket